Search Ontology:
ChEBI
alpha-L-Fucp-(1->2)-beta-D-Galp3Me-(1->4)-beta-D-GlcpNAc
- Term ID
- CHEBI:147699
- Synonyms
-
- 6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-3-O-methyl-beta-D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranose
- alpha-L-fucopyranosyl-(1->2)-3-O-methyl-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- Fuc(a1-2)Gal3Me(b1-4)b-GlcNAc
- N-[(2R,3R,4R,5S,6R)-2,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-methoxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxan-3-yl]acetamide
- Definition
- An amino trisaccharide consisting of α-L-fucopyranose, 3-O-methyl-β-D-galactopyranose and 2-acetamido-2-deoxy-β-D-glucopyranose residues joined in sequence by (1→2) and (1→4) glycosidic bonds.
- References
-
- glygen:G17510DO
- glytoucan:G17510DO
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp3Me-(1->4)-beta-D-GlcpNAc
Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp3Me-(1->4)-beta-D-GlcpNAc
Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp3Me-(1->4)-beta-D-GlcpNAc
Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp3Me-(1->4)-beta-D-GlcpNAc
Human Disease Model